ERBB2 and breast carcinoma: RC-48, RemGen. The mAb is a recombinant humanized anti-Her2 monoclonal antibody-MMAE conjugate for the treatment of Her2-positive advanced breast cancer, urothelial cancer that is inoperable, locally advanced or metastatic, and gastric cancer that is locally advanced or metastatic in nature.